ADMI Announces Agreement with Pennsylvania Health Care Provider.

Business Editors

BERLIN, N.J.--(BUSINESS WIRE)--March 17, 2000

George H. Young, CEO of Asthma Disease Management, Inc. (ADMI), "Healthcare for the New Economy", announced today that it has reached agreement with HMA of Philadelphia, Pennsylvania, a Health Care Maintenance Organization.

With the addition of HMA, ADMI will add substantially to its enrollee base. ADMI will add those enrolled members suffering from asthma on line in an orderly process so that the Company will maintain the integrity and quality of the health care provided.

With ADMI's aggressive marketing program, ADMI expects the number of health care providers will continue to increase in the coming year. ADMI expects sales for the coming twelve months to exceed the projected $6 million made earlier in the year. The company expects that these sales will translate into increased net income for the next 12-month period to exceed $900,000. ADMI expects continued growth in sales during the coming 24 months in the range of $17 million, which will translate into net income of approximately $7 million. For the coming full 36-month period, the company expects sales to increase to $60 million, which could produce net income of up to $21 million.

ADMI is the leader in diagnostic and treatment of asthma and allergic disease in America. Allergy impacts 80 million people in the USA and the number is growing. Allergic disease has a significant impact on asthma, and asthma is a major health problem in this country. Asthma is responsible for 1% of the total health care costs in America and asthma affects more than 13 million people in this country, with an annual cost of illness currently estimated to be well above $15 billion, additionally, asthma is the leading cause of death among children in the inner cities of America

ADMI, very shortly, expects to enter into the direct treatment of the disadvantaged inner-city population of American cities.

This release may contain forward looking statements, made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties which might cause the actual results to differ materially from those projected in any forward looking statements. Factors which could affect results include the development and introduction of competing or superior technologies, the market awareness and acceptance of Disease Management and the overall market demand for Managed Health Care.